npj Vaccines
(Aug 2025)
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques
Payal P. Pratap,
Christopher A. Cottrell,
James Quinn,
Diane G. Carnathan,
Daniel L. V. Bader,
Andy S. Tran,
Chiamaka A. Enemuo,
Julia T. Ngo,
Sara T. Richey,
Hongmei Gao,
Xiaoying Shen,
Kelli M. Greene,
Jonathan Hurtado,
Katarzyna Kaczmarek Michaels,
Elana Ben-Akiva,
Ashley Lemnios,
Mariane B. Melo,
Joel D. Allen,
Gabriel Ozorowski,
Max Crispin,
Bryan Briney,
David Montefiori,
Guido Silvestri,
Darrell J. Irvine,
Shane Crotty,
Andrew B. Ward
Affiliations
Payal P. Pratap
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
Christopher A. Cottrell
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
James Quinn
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
Diane G. Carnathan
Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University
Daniel L. V. Bader
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
Andy S. Tran
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
Chiamaka A. Enemuo
Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University
Julia T. Ngo
Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University
Sara T. Richey
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
Hongmei Gao
Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center
Xiaoying Shen
Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center
Kelli M. Greene
Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center
Jonathan Hurtado
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
Katarzyna Kaczmarek Michaels
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Elana Ben-Akiva
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Ashley Lemnios
Department of Immunology and Microbiology, The Scripps Research Institute
Mariane B. Melo
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
Joel D. Allen
School of Biological Sciences, University of Southampton
Gabriel Ozorowski
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
Max Crispin
School of Biological Sciences, University of Southampton
Bryan Briney
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
David Montefiori
Duke Human Vaccine Institute and Department of Surgery, Duke University Medical Center
Guido Silvestri
Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University
Darrell J. Irvine
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
Shane Crotty
Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute
Andrew B. Ward
Department of Integrative Structural and Computational Biology, The Scripps Research Institute
DOI
https://doi.org/10.1038/s41541-025-01252-4
Journal volume & issue
Vol. 10,
no. 1
pp.
1
– 15
Abstract
Read online
Abstract During infection, the fusion peptide (FP) of HIV envelope glycoprotein (Env) serves a central role in viral fusion with the host cell. As such, the FP is highly conserved and therefore an attractive epitope for vaccine design. Here, we describe a vaccination study in non-human primates (NHPs) where glycan deletions were made on soluble HIV Env to increase FP epitope exposure. When delivered via implantable osmotic pumps, this immunogen primed immune responses against the FP, which were then boosted with heterologous trimers resulting in a focused immune response targeting the conserved FP epitope. Although autologous immunizations did not elicit high affinity FP-targeting antibodies, the conserved FP epitope on a heterologous trimer further matured the lower affinity, FP-targeting B cells. This study suggests using epitope conservation strategies on distinct Env trimer immunogens can focus humoral responses on desired neutralizing epitopes and suppress immune-distracting antibody responses against non-neutralizing epitopes.
Published in npj Vaccines
ISSN
2059-0105 (Online)
Publisher
Nature Portfolio
Country of publisher
United Kingdom
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website
https://www.nature.com/npjvaccines/
About the journal
WeChat QR code
Close